UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. 低カルシウム血症の治療 treatment of hypocalcemia
- 2. 慢性腎疾患を有する小児における骨代謝および腎性骨異栄養症 bone metabolism and renal osteodystrophy in children with chronic kidney disease
- 3. 透析患者における二次性副甲状腺機能亢進症およびミネラル代謝異常のマネージメント management of secondary hyperparathyroidism and mineral metabolism abnormalities in dialysis patients
- 4. 慢性腎疾患を有する透析前の成人患者における二次性副甲状腺機能亢進症およびミネラル
代謝異常のマネージメント management of secondary hyperparathyroidism and mineral metabolism abnormalities in adult predialysis patients with chronic kidney disease - 5. アナフィラキシーの臨床診断を裏付ける臨床検査 laboratory tests to support the clinical diagnosis of anaphylaxis
English Journal
- Synthesis of a novel class of substituted benzothiophene or benzofuran derivatives as BMP-2 up-regulators and evaluation of the BMP-2-up-regulating effects in vitro and the effects on glucocorticoid-induced osteoporosis in rats.
- Xue ST1, Guo HF1, Liu MJ2, Jin J1, Ju DH2, Liu ZY3, Li ZR4.
- European journal of medicinal chemistry.Eur J Med Chem.2015 May 26;96:151-61. doi: 10.1016/j.ejmech.2015.04.016. Epub 2015 Apr 8.
- The BMP pathway is a promising new target for the design of therapeutic agents for the treatment of low bone mass. To enrich our understanding of SAR and based on our previously concluded structure-effect relationship, 23 derivatives were prepared in this work. The synthesis, up-regulating activitie
- PMID 25874339
- Vitamin D3 analogs for the treatment of osteoporosis.
- Hagino H1.
- Canadian journal of physiology and pharmacology.Can J Physiol Pharmacol.2015 May;93(5):327-32. doi: 10.1139/cjpp-2014-0419. Epub 2015 Jan 28.
- Vitamin D supplementation is recommended whenever patients are given therapeutic drugs for osteoporosis, to make their calcium (Ca) balance positive. Vitamin D is converted to 25-hydroxyvitamin D in the liver, and then activated to become 1α,25-dihydroxyvitamin D in the kidneys. The active vitamin
- PMID 25853632
- Effect of Alfacalcidol on multiple sclerosis-related fatigue: A randomized, double-blind placebo-controlled study.
- Achiron A1, Givon U2, Magalashvili D2, Dolev M2, Liraz Zaltzman S2, Kalron A2, Stern Y2, Mazor Z3, Ladkani D3, Barak Y2.
- Multiple sclerosis (Houndmills, Basingstoke, England).Mult Scler.2015 May;21(6):767-75. doi: 10.1177/1352458514554053. Epub 2014 Oct 24.
- CONTEXT: Fatigue is one of the most common and disabling symptoms of multiple sclerosis (MS); however, there is no medication that has been approved specifically to treat MS-related fatigue.OBJECTIVE: We aimed to evaluate the effect of vitamin D analogue, Alfacalcidol, on MS-related fatigue.DESIGN,
- PMID 25344375
Related Links
- Structure, properties, spectra, suppliers and links for: 1-hydroxycholecalciferol. ... Predicted data is generated using the US Environmental Protection Agency’s EPISuite Log Octanol-Water Partition Coef (SRC): Log Kow ...
- 1-hydroxycholecalciferol: RN refers to (1alpha,3beta,5Z,7E)-isomer; a vitamin D analog ... CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library ...
Related Pictures
★リンクテーブル★
| リンク元 | 「1-ヒドロキシコレカルシフェロール」 |
| 関連記事 | 「hydroxycholecalciferol」 |